Mucormycosis in COVID-19 Diabetic Patient

A Review and Case Report

DOI

10.2991/ahsr.k.211012.001How to use a DOI?

Keywords

COVID 19, Mucormycotic, Diabetes

Abstract

Mucormycosis is an unusual and potentially lethal invasive infection of fungi that most commonly affects diabetes and other immunocompromised individuals. This infection showed high morbidity and mortality rate. Furthermore, the rapidity with which mucormycosis spreads is an extraordinary phenomenon; even a minor delay in diagnosis can be lethal. COVID-19–associated mucormycosis has been documented more frequently recently, notably among cases with uncontrolled diabetes. Patients with type I diabetes mellitus and hyperglycemia often have an inflammatory condition exacerbated by suppressed immunity triggered by SARS-CoV-2, making secondary infections more likely. Reports of mucormycosis in Iraq is scrutinized; therefore, we aimed to discuss the infection’s epidemiological criteria, risk factors, and pathogenesis as we present a young child case report who suffered from a tragic course.

Copyright

© 2021, the Authors. Published by Atlantis Press.

Open Access

This is an open access article distributed under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).

Download article (PDF)

TY  - CONF
AU  - Wassan Nori
AU  - Sanaa Norri
PY  - 2021
DA  - 2021/10/12
TI  - Mucormycosis in COVID-19 Diabetic Patient
BT  - Proceedings of the 1st International Ninevah Conference on Medical Sciences (INCMS 2021)
PB  - Atlantis Press
SP  - 1
EP  - 4
SN  - 2468-5739
UR  - https://doi.org/10.2991/ahsr.k.211012.001
DO  - 10.2991/ahsr.k.211012.001
ID  - Nori2021
ER  -